| | Basic and Translational Investigations Preclinical Experimental Therapeutics Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model Elizabeth K. Hellums, James M. Markert, Jacqueline N. Parker, Bin He, Bernard Perbal, Bernard Roizman, Richard J. Whitley, Catherine P. Langford, Suman Bharara, and G. Yancey Gillespie Neuro-oncol. 2005 July; 7(3): 213–224. doi: 10.1215/S1152851705000074.PMCID: PMC1871915 Tumor Biology Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1α expression in human glioma cells by a proteasome-independent pathway: Implications for in vivo therapy Elizabeth W. Newcomb, M. Aktar Ali, Tona Schnee, Li Lan, Yevgeniy Lukyanov, Mary Fowkes, Douglas C. Miller, and David Zagzag Neuro-oncol. 2005 July; 7(3): 225–235. doi: 10.1215/S1152851704000997.PMCID: PMC1871916 Medical Neuro-Oncology Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo Antonietta Arcella, Giulia Carpinelli, Giuseppe Battaglia, Mara D’Onofrio, Filippo Santoro, Richard Teke Ngomba, Valeria Bruno, Paola Casolini, Felice Giangaspero, and Ferdinando Nicoletti Neuro-oncol. 2005 July; 7(3): 236–245. doi: 10.1215/S1152851704000961.PMCID: PMC1871912 Clinical Investigations Clinical Therapy Trials-Drug Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma, Steven Brem, Stuart A. Grossman, Kathryn A. Carson, Pamela New, Surasak Phuphanich, Jane B. Alavi, Tom Mikkelsen, and Joy D. Fisher Neuro-oncol. 2005 July; 7(3): 246–253. doi: 10.1215/S1152851704000869.PMCID: PMC1871917 Retrospective Clinical Studies High failure rate in spinal ependymomas with long-term follow-up Daniel R. Gomez, Brian T. Missett, William M. Wara, Kathleen R. Lamborn, Michael D. Prados, Susan Chang, Mitchel S. Berger, and Daphne A. Haas-Kogan Neuro-oncol. 2005 July; 7(3): 254–259. doi: 10.1215/S1152851704001231.PMCID: PMC1871913 Review Tumor Biology Chaperone proteins and brain tumors: Potential targets and possible therapeutics Michael W. Graner and Darell D. Bigner Neuro-oncol. 2005 July; 7(3): 260–277. doi: 10.1215/S1152851704001188.PMCID: PMC1871914 Abstracts Abstracts from the World Federation of Neuro-Oncology Second Quadrennial Meeting and the Sixth Meeting of the European Association for Neuro-Oncology: May 5–8, 2005, Edinburgh, United Kingdom Neuro-oncol. 2005 July; 7(3): 279–402. doi: 10.1215/ S1152851705200388.PMCID: PMC1871910 Society News and Announcements SOCIETY NEWS AND ANNOUNCEMENTS Neuro-oncol. 2005 July; 7(3): 421–422. doi: 10.1215/S1152851705200170.PMCID: PMC1871911 |